CHAD M HIVNOR
Allopathic & Osteopathic Physicians|Dermatology SAN ANTONIO, TX NPI 1477544476
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology TX Lumenis BE inc All categories
General Payments — all program years on this page
$16,021.68
- Category: General Payments
- Program years: PY2018–2024
- Record count: 115
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,721.62 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,721.62 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE inc | $1,319.98 | 1 |
| ABBVIE INC. | $293.22 | 2 |
| GENZYME CORPORATION | $34.38 | 2 |
| REVANCE THERAPEUTICS, INC. | $27.23 | 1 |
| Krystal Biotech Inc | $27.20 | 1 |
| Arcutis Biotherapeutics, Inc. | $19.61 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082155284 | Lumenis BE inc | $1,319.98 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1084810486 | Krystal Biotech Inc | $27.20 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103923371 | ABBVIE INC. | $150.27 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103923373 | ABBVIE INC. | $142.95 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121039298 | Arcutis Biotherapeutics, Inc. | $19.61 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139705831 | GENZYME CORPORATION | $18.08 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139705869 | GENZYME CORPORATION | $16.30 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147920208 | REVANCE THERAPEUTICS, INC. | $27.23 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.